C-POLAR Technologies, Inc., is a global company with headquarters in the United States, a research and development center in Canada, and European offices in Ireland & the United Kingdom. It is an international bioprotection leader offering revolutionary protection against viruses, microorganisms, and fungi amid the rising prevalence of global outbreaks. C-POLAR™—which stands for cationic polarization — is based on fundamental physics. Studies show that when C-POLAR™ is applied to selected materials, the materials are imbued with a stable positive charge that effectively captures and eradicates 99.99% of viruses, bacteria, molds, fungi, and pollens. C-POLAR™ creates and enables infection-resilient environments of the future — setting a new global standard for health and safety for governments, private enterprises, hospitals, and schools.